Navigation Links
Boston Scientific to Participate in Piper Jaffray PCR Post-Op Summit
Date:5/15/2009

NATICK, Mass., May 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray PCR Post-Op Summit in London.

Jim Tobin, President and Chief Executive Officer, will participate in a 40-minute question and answer session on Friday, May 22, beginning at approximately 9:30 a.m. London time.

A live webcast of Mr. Tobin's remarks will be available to all interested parties at Boston Scientific's website at www.bostonscientific.com Please visit for details on how to access the webcast. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins.

This webcast is being hosted by Piper Jaffray. The replay will be archived and available in the Investor Relations site at www.bostonscientific.com on May 22 at approximately one hour after the conclusion of the session.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com

    CONTACT:  Paul Donovan
              508-650-8541 (office)
              508-667-5165 (mobile)
              Media Relations
              Boston Scientific Corporation

              Larry Neumann
              508-650-8696 (office)
              Investor Relations
              Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Raytheon Donates $100,000 to Fisher House Boston
2. Boston Scientific Announces Schedule for EuroPCR 2009
3. First Boston Pharma, LLC Acquires NutraMax Products, Inc.
4. Nektar Therapeutics to Present at the Deutsche Bank 34th Annual Health Care Conference in Boston
5. Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
6. Children's Hospital Boston Advances Cutting-Edge Technologies with its New Technology Development Fund
7. Derma Sciences Announces Voluntary Delisting from the Defunct Boston Stock Exchange
8. Boston Scientific to Participate in Bank of America and Merrill Lynch Conference
9. Wounded Warrior Project (WWP) Announces Support for Soldier Ride from Boston Scientific
10. Boston Scientific Announces Results For First Quarter Ended March 31, 2009
11. Equinox Fitness Clubs Continues National Expansion with the Opening of its Second Boston Location
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... thought leadership , media relations, content marketing, social media management, corporate communications, ... clients already in the state and in nearby New Hampshire, Massachusetts and Canada, ...
(Date:2/23/2017)... ... , ... Dr. David Mahon leads Siena Dental, a comprehensive dental practice located ... 2017 Top Patient Rated Henderson Dentist by Find Local Doctors earlier this ... and dentists who have earned high ratings and superior patient reviews from multiple credible ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... announced today that it will soon begin franchising throughout the U.S. starting this ... to help bring the practice of meditation mainstream. Current Meditation will be the ...
(Date:2/23/2017)... VA – , ... ... coming. It’s the perfect opportunity for the nation to come ... a college basketball bracket – with its favorite fruit – ... is encouraging apple lovers to join the “Apple Madness” bracket ...
(Date:2/23/2017)... ... ... Curemark, LLC announced today that the Blüm Study, a Phase 3 clinical ... Autism, is now enrolling at three new sites. These new sites are in addition ... “There are currently no approved drugs that address the core symptoms of autism,” said ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Research and Markets has announced the addition ... report to their offering. ... The latest research Fibromyalgia Drugs Price Analysis and ... global Fibromyalgia market. The research answers the following questions: ... Fibromyalgia and their clinical attributes? How are they positioned in the ...
(Date:2/23/2017)... Feb. 23, 2017 Regulus Therapeutics Inc ... and development of innovative medicines targeting microRNAs, today announced ... financial results on Thursday, March 2, 2017 after the ... call and webcast on March 2, 2017 at 5:00 ... year 2016 financial results and provide a general business ...
(Date:2/23/2017)... PUNE, India , February 23, 2017 ... "Diagnostic Imaging Market by Product (X-ray Imaging Digital, Analog), ... PET)), Application (OB/GYN, MSK, Cardiology, Oncology), End User (Hospitals, ... MarketsandMarkets, the report studies the global market over the ... expected to reach ~USD 36.43 Billion by 2021, at ...
Breaking Medicine Technology: